Investing
Thursday's Top Analysts Upgrades and Downgrades: Apple, Darden Restaurants, Peloton, Pfizer, Pioneer Natural Resources and More
May 6, 2021 8:48 am
Last Updated: August 9, 2021 11:18 am
Arco Platform Ltd. (NASDAQ: ARCE): Morgan Stanley raised the stock to Overweight from Equal Weight and has a $32.50 price target. The consensus target is up at $44.81, and the shares closed on Wednesday at $25.02.
Astec Industries (NASDAQ: ASTE): Stifel’s upgrade to Buy from Hold included a price target hike to $81 from $75. The posted consensus target is $82.33. The stock closed Wednesday at $65.95, down almost 15% for the day, after earnings came in way below expectations.
Cumulus Media Inc. (NASDAQ: CMLS): B. Riley Securities raised the stock to Buy from Neutral and has a $14 price target. The consensus target is $11.33. The stock closed trading on Wednesday at $9.00.
Darden Restaurants Inc. (NYSE: DRI): Cowen raised its Market Perform rating to Outperform and its price target went from $137 to $164. The consensus target is $155.76, and the last Wednesday trade came in at $142.23.
FMC Corp. (NYSE: FMC): Citigroup downgraded it to Neutral from Buy and has a $126 price target. The consensus target is higher at $132.21m and the closing price on Wednesday was $121.83 a share.
Maxeon Solar Technologies Ltd. (NASDAQ: MAXN): Though Raymond James upgraded the shares to Strong Buy from Outperform, the firm also lowered the price target to $33. The consensus target is $27.67, and the Wednesday close was at $15.43, which was down almost 8% for the day.
24/7 Wall St.MercadoLibre Inc. (NASDAQ: MELI): Stifel raised the shares to Buy from Hold and has a $1,800 price target. The consensus target is even higher at $1,912.57, and Wednesday’s closing price was $1,530.54.
Mercury Systems Inc. (NASDAQ: MRCY): Jefferies upgraded the stock to Buy from Hold and has an $80 price target. The consensus target is up at $91.75m and the last trade on Wednesday came in at $57.69, and the stock pulled back almost 18% on the day. The company slightly beat estimates but announced very weak forward guidance.
Neurocrine Biosciences Inc. (NASDAQ: NBIX): Barclays upgraded the shares to Overweight from Equal Weight and has a $110 price target. The consensus target is $127.55, and the stock ended Wednesday’s trading session at $91.60 a share.
Paya Holdings Inc. (NASDAQ: PAYA): Credit Suisse started coverage with an Outperform rating and a $14 price target. The consensus target is higher $15.43, and the final Wednesday price was reported at $10.57.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Editors' Picks
